Jul 29, 2025 | Biologics, Biosimilar, Cost Savings, MedBen Rx, Pharmacies, Pharmacy Benefits Manager (PBM), Prescription drugs, Rx Costs, Savings
The advantages of biosimilars – clinically equivalent versions of high-price biologic drugs – have been known for years. But despite their growing availability, adoption remains slow… in no small part because major PBMs are stifling uptake....
Nov 12, 2022 | Biologics, MedBen Rx
From earlier this year: “The global biologics market is expected to see a 12% growth rate and reach $420.55 billion by 2025, according to a new report by The Business Research Company.” A drug therapy originating from living organisms, biologics is a...
